Sermorelin
GHRH analog that stimulates natural growth hormone release.
300 mcg/day (mid-range daily dose)
Key Benefits
triggers the pituitary to release growth hormone in its natural pulsatile pattern, unlike synthetic GH injections
research shows improved lean muscle mass and reduced fat mass over 3–6 month protocols
demonstrated increases in slow-wave (deep) sleep, the phase most critical for recovery and cellular repair
elevated GH and IGF-1 accelerate tissue repair, reduce recovery time between training sessions, and support joint health
Recommended Injection Sites
Optimal injection locations for Sermorelin based on its route (Subcutaneous injection) and pharmacokinetic profile.
Tap a glowing zone on the body map to highlight the matching site card — or tap a card to activate the zone.
Tap a zone to inject
Preferred site for GHRH analogs. Consistent SubQ absorption; easy to self-administer pre-sleep.
Reliable alternative. Slightly slower onset — still appropriate for pre-sleep timing.
Use only if abdomen/thigh are unavailable. Thinner SubQ layer requires careful needle depth.
Rotate within the abdominal quadrants nightly. Mark injection points to avoid repeating the same spot within 7 days.
- IV administration
- Intramuscular injection
- Lipodystrophic tissue
Active Signaling Pathway
Sermorelin binds GHRH receptors on the pituitary, triggering pulsatile GH release that mirrors the body's natural nocturnal pattern. GH then travels systemically to stimulate IGF-1 production in the liver.
Recommended Stacks
Sermorelin is a key compound in these curated research stacks. Pair it with synergistic peptides for enhanced outcomes.
Lean Body Recomposition
Build lean muscle while burning fat simultaneously — the holy grail of body composition research.
Peak Recovery & Injury Repair
Accelerate tissue repair, reduce inflammation, and get back to peak performance faster.
How long will one vial last?
Based on standard research protocols, here's exactly what to expect from a single 5mg vial — and when to plan your next order.
Actual duration may vary based on your specific protocol. Always consult your research guidelines for precise dosing schedules.
Scientific Background
Mechanism of Action
Sermorelin is a 29-amino acid peptide corresponding to the first 29 amino acids of endogenous GHRH. It binds to GHRH receptors on somatotroph cells in the anterior pituitary, triggering a cAMP-mediated signaling cascade that results in GH synthesis and pulsatile release. Unlike exogenous GH, Sermorelin preserves the natural feedback loop via somatostatin.
Clinical Context
Sermorelin has one of the longest clinical track records of any GHRH analog. Its short half-life (~10–20 min) means it mimics the natural pulsatile pattern of GH release when dosed pre-sleep, aligning with the body's largest natural GH pulse. This physiological dosing pattern is considered superior to continuous GH elevation.
Research Highlights
- FDA-approved (1997) for GH deficiency in children; well-characterized safety profile from clinical use
- Studies show 20–30% increase in IGF-1 levels in GH-deficient adults after 3–6 months of therapy
- Demonstrated improvements in sleep architecture (increased slow-wave sleep) in aging subjects
- Unlike direct GH administration, Sermorelin does not suppress endogenous GH axis — pituitary remains responsive
Storage & Reconstitution
Best administered before sleep to align with natural GH pulsatility. Reconstitute with bacteriostatic water.